Thalomid^®

Thalomid^® - The trade name for thalidomide, Thalomid^® was originally developed during the 1950s as a treatment for insomnia and morning sickness (it was later discovered that the drug caused severe birth defects). Thalomid^® is now a drug used in multiple myeloma treatment, particularly in newly-diagnosed patients. Thalomid^® belongs to the family of drugs called angiogenesis inhibitors. Although the exact ways in which Thalomid^® works remain unclear, it has been shown to inhibit the formation of blood vessels, and thereby stop the growth and survival of myeloma cancer cells in the body.

Previous: Testicular Cancer Treatment

Next: TheraSphere^®

Back to the Cancer Glossary